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Abstract:  
Aim: To investigate human oral mucosal fibroblasts (HOMF) and human limbal fibroblasts (HLF) as 
alternatives to murine 3T3 feeder fibroblasts currently used to support epithelial cell expansion for 
the treatment of limbal epithelial stem cell deficiency.  
Methods: HLF and HOMF were compared to 3T3 for their ability to support the culture of human 
limbal epithelial cells (HLE) and human oral mucosal epithelial cells. 
Results: HOMF, but not HLF, were equivalent to 3T3 in terms of the number of epithelial population 
doublings achieved. HLE co-cultured with HOMF or 3T3 had similar expression of corneal and 
putative stem cell markers. 
Conclusion:  HOMF are a suitable and safer feeder fibroblast alternative to 3T3 for the production of 
epithelial cells for clinical use. 
Keywords: cornea, oral mucosa, limbal epithelial stem cell deficiency, stem cell therapy, limbal 
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Introduction 
The corneal surface is maintained and repaired by a population of stem cells thought to reside in the 
limbus called limbal epithelial stem cells (LESC). Injury or disease can result in a deficiency of these 
LESC, a condition known as limbal stem cell deficiency (LSCD). In LSCD the cornea becomes opaque 
as the conjunctival epithelium migrates across the limbus and onto the cornea. This affects vision, 
and is accompanied by inflammation, vascularisation, and severe discomfort. LSCD has been 
successfully treated using cultured cell therapies: cultivated limbal epithelial transplantation (CLET) 
and cultivated oral mucosal epithelial transplantation (COMET).  
Multiple protocols for ex-vivo expansion of limbal epithelial cells have been successfully used to 
treat patients with LSCD (reviewed by Tseng et al. [1]). The starting point for these therapies is a 
small limbal biopsy taken from the healthy eye of the patient if available (unilateral disease), or from 
a donor eye for cases where both eyes are affected by LSCD (bilateral disease). One of the 
differences is whether HLE are obtained from the biopsy by explant culture or as a single cell 
suspension. The majority of these methods utilise 3T3s as feeder cells, either in direct or indirect 
contact with HLE. In this study epithelial cells were isolated from limbal or oral mucosal tissue as a 
single cell suspension, and expanded by co-culturing with 3T3, HLF or HOMF feeder fibroblasts i.e. 
direct contact approach. COMET is used for patients with bilateral LSCD, where a small oral biopsy is 
taken from the patient from which to culture oral mucosal epithelial cells. An advantage of COMET 
over using donor HLE is that autologous (patient’s own) cells can be used thus eliminating the need 
for immunosuppression and its associated side effects. For COMET, 3T3s have been used in nearly all 
clinical studies for ex-vivo expansion of HOME (reviewed by Utheim et al. [2]).  
In the limbal stem cell “niche”, the microenvironment which controls/regulates stem cell fate, the 
stem cells are in close contact with niche cells [3]. It has been suggested that 3T3s act as a surrogate 
niche cell for HLE culture [1]. For HLE isolated from limbal tissue as a single cell suspension, direct 
contact between 3T3s and HLE has been shown to be important for initiating epithelial colonies on 
tissue culture plastic [4]. Indirect contact with 3T3s has been shown to be beneficial for delaying 
epithelial differentiation for explant cultured HLE on denuded amniotic membrane [5]. A 
combination of direct and indirect contact between 3T3 feeder cells and HLEs has been shown to 
produce more progenitor cells than direct or indirect contact alone [4].  
Safety and efficacy are both important considerations for GMP. The use of a 3T3 feeder layer is 
currently the gold standard method for culturing and maintaining epithelial stem cells. Although 
3T3s are murine derived cells and cell therapies should ideally be animal product free, this culture 
method is currently optimal and is approved for clinical use until a suitable alternative can be found. 
Although there is no evidence to suggest that 3T3s have had a harmful effect for patients, and very 
few if any 3T3s would be transferred with the epithelial graft to the patient [6], it is important to 
ensure that cell grafts are as safe as possible. In order to fully eliminate the risk of 3T3s transmitting 
murine viruses to human cells, these cells would need to be removed from the culture process.  
The use of human derived feeder fibroblasts represents an alternative to 3T3s and has been 
investigated for several fibroblast types [7-11], although these have yet to be used in the clinic. 
Although there are advantages in using a cell line such as reducing variability between different 
donor cells, the use of allogeneic (donor) human fibroblasts still carries a risk of disease transfer to 
the patient. A human-derived feeder fibroblast cell line could be banked and screened for 
adventitious agents. However, in addition to removing any risk of disease transfer, using autologous 
feeder fibroblasts for autologous epithelial expansion would also remove the need for 
immunosuppression. The aim of this study was to investigate whether human derived limbal or oral 
mucosal fibroblasts could be used as alternative feeders to the gold standard 3T3 for the expansion 
of epithelial cells for use in the clinic. HLF and HOMF were studied for their ability to support the 
expansion of HLE and HOME. Autologous HLF could be obtained for patients with unilateral LSCD, 
and autologous HOMF for patients with unilateral or bilateral LSCD. To our knowledge the use of 
HOMF as a feeder fibroblast for the culture of epithelial cells for the treatment of LSCD has not 
previously been reported, nor has using HLF as a feeder fibroblast for HOME. The use of HLF as a 
feeder fibroblast for HOME was investigated to see if these cells would be useful for inducing a more 
corneal phenotype in HOME.  
 
Methods 
HLE and HOME were initially expanded in T25 tissue culture flasks on Mitomycin C growth arrested 
3T3 (primary culture) and cryopreserved. Following cryopreservation, the epithelial cells were split 
equally (1:3) between the following: 1) T25 with growth arrested HLF, 2) T25 with growth arrested 
HOMF, and 3) T25 with growth arrested 3T3. Epithelial cells were then passaged (at a seeding 
density of 1.5x104 epithelial cells/cm2) onto the same fibroblast feeder type until they ceased to 
proliferate. Colony forming efficiency assays were set up at each passage. Protein and RNA were 
isolated from epithelial cells for PCR and Western blotting experiments. RNA was isolated from 
passage 2 epithelial cells. Protein was isolated from passage 1 HLE (cultured as described), and from 
passage 3 HOME with the following alteration to the culture method: HOME cultured on 3T3 for 
primary and passage 1 expansions prior to being split equally between 3T3, HLF and HOMF feeder 
layers (passage 2).  
Initial expansion on 3T3 was performed to enable scheduling of all the different feeder layers to be 
ready at the same time for primary epithelial cells to be passaged onto as supply of limbal tissue is 
not predictable, nor is the exact length of primary culture time to reach confluency. Also, we had a 
limited supply of HOMF if low/comparable passage numbers were to be used for the duration of the 
experiment. HLE were also co-cultured with HOMF from isolation (primary culture) to see if 
epithelial cultures could be initiated on HOMF.  
Isolation and culture of HLE: 
HLE were isolated from cadaveric limbal rims (in accordance with EU research consent and ethics 
approval requirements). Each rim was immersed in 1.2U/ml Dispase II (Roche Diagnostics) for either 
1-2 hours at 37ºC or overnight at 4ºC. The rim was removed from Dispase and the epithelial cells 
scraped from the limbal region of the tissue. Cells were then suspended in Corneal Epithelial Culture 
Medium (CECM) and seeded into a T25 tissue culture flask containing growth arrested 3T3 (for 
Figure 7, HLE were seeded onto growth arrested HOMF). CECM  consists of the following: 3:1 
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM:F12) (Life Technologies) with 10% 
fetal bovine serum (FBS) (Life Technologies), 0.4μg/ml hydrocortisone (Sigma), 0.1nmol cholera toxin 
(Sigma), 5μg/ml insulin (Sigma), 1x antibiotic/antimycotic (Life Technologies), 0.18mmol adenine 
(Sigma), 2nmol triiodothyronine (T3) (Sigma), 5μg/ml transferrin (Sigma), and 10ng/ml epidermal 
growth factor (EGF) (Life Technologies) plus 0.075% sodium bicarbonate (Life Technologies). Culture 
medium was changed three times a week and HLE were passaged before they became confluent. All 
cells were cultured in the presence of 5% CO2 in air at 37ºC. 
 
Isolation and culture of HOME 
Oral mucosal biopsies were taken from healthy volunteers (with appropriate research consent and 
ethics approval). Patients were asked to rinse their mouth with chlorhexidine 0.2% mouthwash 
(Corsodyl, GlaxoSmithKline Ltd) for 10 minutes and biopsies were harvested under local anaesthetic. 
Briefly 1% tetracaine was applied topically to the buccal mucosa using cotton buds followed by 
submucosal injection of  0.3ml Xylocaine 2% with adrenaline (1:200,000) Astra Zeneca UK Ltd.  A 
3mm diameter punch biopsy (Stiefel) was used to trephine through the epithelium into the 
submucosa. The epithelium and a small amount of superficial submucosal tissue was then excised 
using a toothed forceps and Westcott scissors (Duckworth and Kent, UK). Each oral mucosal biopsy 
was immersed 3 times in disinfection solution: D-PBS (Life Technologies) + 0.5X antibiotic – 
antimycotic (diluted from 100X antibiotic-antimycotic containing 10,000units/ml Penicillin, 
10,000µg/ml Streptomycin and 25µg/ml Amphotericin B, Life Technologies) plus 5µg/ml 
Amphotericin B (Sigma) for 10 mins at room temperature. Biopsies were subsequently placed in 
1.2IU Dispase II (Roche Applied Science) and incubated at 37˚C for 1 hour. The biopsy was then 
treated with 0.25% trypsin:EDTA (diluted from 0.5% trypsin:EDTA from Life Technologies) for 30mins 
at room temp. Culture medium (CECM) was used to quench the trypsin and the tissue gently scraped 
using forceps. The resulting cell suspension was centrifuged for 5 mins and the resulting pellet 
resuspended in culture medium and plated onto a Mitomycin C growth arrested 3T3 feeder layer in 
a T25 tissue culture flask. Culture media was changed three times a week and HOME passaged 
before they became confluent.  
HOME were also cultured in serum-free media for 2 reasons. Firstly to confirm that PAX6 expression 
was not due to any fibroblasts remaining in the HOME samples tested, and secondly to see if PAX6 
expression was a result of using fibroblasts in the culture process. PAX6 expression was compared 
for HOME obtained using the epithelial-fibroblast co-culture method, the feeder-free culture 
method, and also for fibroblast only samples (HLF, HOMF, and 3T3). For keratinocyte serum free 
medium (KSFM) cultured HOME, the following procedure was used: HOME were isolated using the 
same procedure described above but HLF medium was used to quench the trypsin, cells were re-
suspended in defined KSFM (Life Technologies) following centrifugation and plated onto a T25 flask 
coated with collagen type I (rat tail) (First Link UK Ltd). Flasks were coated with 0.3mg/ml collagen in 
3% acetic acid for 1 hour at 37˚C, and washed three times with PBS prior to seeding HOME on top. 
Upon reaching 70% confluence, cells were detached using 0.05% trypsin:EDTA at 37˚C for 10 
minutes, quenched with HLF medium, spun down and re-suspended in KSFM before being split 1:3 
onto T25s coated with collagen I. Once these passage 1 cultures were 70% confluent, protein and 
RNA were extracted for PCR and Western blotting experiments. 
Differential trypsinisation for removal of fibroblasts from epithelial cultures: 
 
Epithelial cells and fibroblasts were separated from cultures using differential trypsinisation in which 
1xtrypsin:EDTA is firstly used to remove the fibroblasts. The epithelial cells remain attached to the 
tissue culture surface and are subsequently detached using 10x trypsin:EDTA [12]. Cultures are 
thoroughly observed under a microscope to ensure that only cells with an epithelial phenotype 
remain attached to the tissue culture plastic following the first trypsinisation step. 
 
When epithelial cells (HLE and HOME) were ready for passaging, differential trypsinisation was used 
to remove feeders (3T3, HLF and HOMF) from the culture and obtain an epithelial cell suspension. 
CECM was added to the harvested epithelial cells prior to centrifuging at 80-100g for 5 minutes. The 
cell pellet was then re-suspended in CECM and the epithelial cells ready to be seeded onto a growth 
arrested feeder layer.  
 
Isolation and culture of HOMF 
Following isolation of HOME from buccal oral mucosal biopsies, the remaining tissue was explant 
cultured in the bottom of a 6 well plate to produce HOMF using the following culture media: DMEM 
+ glutamax, 10% FBS, and 1x antibiotic antimycotic (Life Technologies). Following initial expansion, 
these fibroblasts were passaged at a ratio of 1:3. 
 
Isolation and culture of HLF 
Following isolation of HLE from limbal tissue, explant cultures were set up for limbal fibroblasts. The 
explants from one rim were placed in three T25 tissue culture flasks. Explants were cultured in 
DMEM+glutamax with 10% FBS and 1x antibiotic antimycotic. Following initial expansion, these 
fibroblasts were passaged at a ratio of 1:3.   
Culture of 3T3 
3T3 J2s were cultured in DMEM + glutamax, 10% adult bovine serum (ABS), and 1x antibiotic 
antimycotic (Life Technologies) and passaged at a ratio of up to 1:8. 
Growth arrest of fibroblasts. 
3T3 fibroblasts were treated with 4μg/ml Mitomycin C (Movianto or Sigma) in 3T3 culture medium 
for 2 hours at 37˚C with 5% CO2. HLF and HOMF were treated with 10μg/ml Mitomycin C in culture 
medium for 3 hours at 37˚C with 5% CO2 in culture media. Fibroblasts were then washed with 
Phosphate-Buffered Saline (PBS), and detached from the tissue culture flask using 1xtrypsin:EDTA. 
Culture medium was then added to the growth arrested fibroblasts which were then centrifuged at 
80-100g for 5 minutes, and the supernatant removed. 3T3 were seeded at 2.7x104 cells/cm2, and HLF 
and HOMF at 1.2x104 cells/cm2. Cells were allowed to attach for at least 2 hours, and the culture 
media replaced with CECM before seeding epithelial cells on top. 
 
Population doublings 
 
The number of population doublings was calculated using the following equation which takes into 
account the colony forming efficiency of the cells [13]: 
 
Number of population doublings = 3.322log (N/N0). 
 
Where N = the total number of cells obtained at each passage and N0 = the number of 
clonogenic cells. Colony forming efficiency assay was performed as follows: 
 
For the CFE assay 100-1000 HLE or HOME were seeded per well of a six well plate containing 2x105 
growth arrested 3T3 per well. Cells were cultured for 7 to 12 days in CECM and supplemented with 
additional feeders if necessary. Cells were fixed with ice-cold methanol and stained with 2% 
rhodamine B (Sigma). The total number of colonies was counted using Image J software, and the 
following equation was used to calculate the colony forming efficiency: 
 
CFE (%) = (Number of colonies/Number of epithelial cells seeded) x 100 
 
The population doublings during the primary culture were not included in the calculation since 
epithelial cells were initially expanded on 3T3. The number of population doublings calculated is 
from passage 1 onwards when the epithelial cells were split equally between the 3 different feeder 
fibroblast groups. Thus the number of population doublings described in this study refers to those 
obtained on that particular feeder layer only following primary expansion on 3T3 to ensure results 
are comparable. Population doublings were calculated for multiple passages of epithelial cells from 
passage 1 to senescence. 
 
 
 
Polymerase chain reaction (PCR) 
Primer Sequence Annealing 
temp (˚C) 
Number 
of 
cycles 
Product 
size 
Sequence 
reference 
ABCG2 F: AGTTCCATGGCACTGGCCATA 
R: TCAGGTAGGCAATTGTGAGG 
46 32 379 [14] 
CK12 F: 
ACATGAAGAAGAACCACGAGGATG 
R: TCTGCTCAGCGATGGTTTCA 
60 35 150 [15] 
CK15 F:GGAGGTGGAAGCCGAAGTAT 
R: GAGAGGAGACCACCATCGCC 
60 32 194 [16] 
∆Np63α F: GGAAAACAATGCCCAGACTC 
R: ATGATGAACAGCCCAACCTC 
60 35 1389 [17] 
GAPDH F: GCCAAGGTCATCCATGACAAC 
R: GTCCACCACCCTGTTGCTGTA 
55 35 498 [15] 
MUC16 F: 
GCCTCTACCTTAACGGTTACAATGAA 
R: GGTACCCCATGGCTGTTGTG 
60 35/30 114 [18] 
PAX6 F: ATA ACC TGC CTA TGC AAC CC 
R: GGAACTTGAACTGGAACTGAC 
55 35 208 [15] 
Table 1. Primers used for PCR. 
 
Fibroblasts were removed from cultures by differential trypsinisation with 1Xtrypsin:EDTA prior to 
harvest of the epithelial cells with 10Xtrypsin:EDTA. RNA was isolated from cells using the RNeasy 
Plus Mini Kit (Qiagen GmbH, Hilden,Germany) and quantified using an Eppendorf Biophotometer. Of 
each sample, 1µg was used to synthesise cDNA using the Roche AMV reverse transcriptase kit 
(Roche Diagnostics GmbH, Mannheim, Germany) following treatment with DNase I (Life 
Technologies) and subsequent inactivation of the enzyme. Alternatively the Quantitect Reverse 
Transcriptase kit (Qiagen) was used (figure 6). Equal amounts of cDNA were used for PCRs using the 
primers listed in Table 1.  Each cDNA product (1µl) was mixed with the following:  1µl 5µM forward 
primer, 1µl 5µM reverse primer, and 6µl MegaMixBlue (Helena Biosciences). The thermocycling 
program used was: 94ºC for 2 minutes, then 35 cycles (or other as indicated in table 1) of the 
following: 30 seconds at 94ºC, 30 seconds at the annealing temperature, and 1 minute at 72ºC. The 
final step was 7 minutes at 72ºC. Agarose gel electrophoresis was used to visualise PCR products, 
with Hyperladder II (Bioline Reagents Ltd) as a molecular weight marker. No sample and no reverse 
transcriptase controls were also performed. 
 
Western blotting 
Fibroblasts were removed from cultures using 1xtrypsin:EDTA prior to protein extraction from 
epithelial cells. Protein was extracted using RIPA buffer (Thermo Scientific) plus Halt Protease 
Inhibitor and EDTA (Thermo Scientific), and quantified using the Pierce BCA protein assay kit 
(Thermo Scientific). Western blotting with 40µg of each sample (25µg for figure 6) was performed as 
previously described [19] but with 3x10minute washes rather than 3x20minute washes for the 
following antibodies: Cytokeratin 15 (CK15) (Abcam, AB52816), PAX6 (rabbit, Covance, PRB-278P), 
and GAPDH (Millipore, MAB374). For Mucin 16 (MUC16) (Abcam, AB134093) the following buffer 
was used for blocking and primary antibody incubation: TBST (1xTBS, 0.1% Tween20) + 5% BSA. TBST 
was used as a dilution buffer for the secondary antibody incubation step. For p63α (Cell Signaling 
Technology, 4892) manufacturer’s instructions were followed for blocking, washing and antibody 
incubation steps. Primary antibody dilutions and the predicted molecular weights of the protein 
bands of interest are shown in table 2. The secondary antibodies used were goat anti-mouse HRP 
(P0447, Dako) (1:10,000) and goat anti-rabbit HRP (P0448, Dako) (1:5000-1:10,000). Image J 
software was used for densitometric analysis, and results normalised to GAPDH. Results were 
obtained from 3 different donors (3 HLE donors, and 3 HOME donors) for each epithelial-fibroblast 
combination. For each gel, one set of HLE protein samples (i.e. from the same donor) cultured with 
the 3 different feeder types was loaded alongside one set of HOME protein samples to allow 
comparison. Results from the 3 HLE and 3 HOME experiments were normalised to the gold standard 
HLE-3T3 culture and one way ANOVA performed.  
Antibody Raised in Dilution Predicted Mwt in kDa 
CK15  Rabbit 1:10,000 45 (observed 45 and 50 bands) 
GAPDH  Mouse 1:1500 38 
MUC16  Rabbit 1:10,000 2353 (observed bands starting at approximately 140)  
p63α Rabbit 1:800-1:1000 75 
PAX6  Rabbit 1:500 47-50 
Table 2. Antibody dilutions used for western blotting and the predicted molecular weights of the 
protein bands of interest from the manufacturers datasheets. Where bands observed in this study 
differed from the predicted size this is indicated. 
Results 
Passage number and Population doublings 
All epithelial types were successfully expanded on all fibroblast feeder layers as shown in Figure 1. 
Oral fibroblasts were comparable to 3T3 as a feeder layer for both limbal and oral epithelial cells in 
terms of the number of population doublings (Figure 2) with no significant difference between these 
feeder types. The number of epithelial population doublings (both oral and limbal) achieved with 
limbal fibroblasts as a feeder layer was significantly lower (P<0.05) than with the gold standard 3T3. 
 The average (mean) number of passages obtained for limbal epithelial cells cultured on 3T3, limbal 
and oral fibroblasts was 7, 3 and 6.7 respectively. Higher passage numbers were obtained for oral 
epithelial cells cultured on the 3 different feeder layers with the average (mean) passage numbers 
being 10, 5 and 10.3 for 3T3, limbal and oral fibroblasts respectively.  
For HLE, the mean number of population doublings obtained with 3T3, HLF and HOMF was 38.4, 9.3, 
and 35.1 respectively. For HOME these values were 41.7, 19.3, and 52.1 respectively.  
Stem cell marker expression 
PCR showed that the putative stem cell markers p63α, ABCG2, and CK15 were present in all cellular 
combinations studied (Figure 4) Western blot showed protein expression of p63α and CK15 in all 
conditions (Figure 5). For CK15, two bands of approximately 50kDa and 45kDa in size were observed 
by western blot. The upper band (50kDa) was observed in both oral and limbal epithelial cells, but 
the lower band (45kDa) was present only in the limbal cultures. A431 (human epidermoid carcinoma 
cell line) cell lysate (Santa Cruz Biotechnology) was used as a positive control for CK15 and also had 
two bands. Protein expression of p63α was not significantly different for any of the epithelial-
fibroblast combinations (one way ANOVA). CK15 was significantly lower in oral epithelial cells 
expanded on all 3 feeder fibroblast types compared to limbal epithelial cells co-cultured with 3T3s 
(P<0.05), but was not significantly different for limbal epithelial cells cultured on the different feeder 
fibroblasts. Oral epithelial cells co-cultured with oral fibroblasts had significantly lower CK15 
compared to when cultured on 3T3s (P=0.0299). 
Corneal marker expression 
PAX6 and CK12 are expressed in the cornea and therefore their gene expression was determined to 
see if limbal fibroblasts could drive the oral epithelial cells towards a more corneal phenotype in 
culture. PAX6 mRNA was expressed in oral cells irrespective of the fibroblast feeder layer albeit at a 
“low signal level”; western blotting also showed a faint band for PAX6 in these cultures (Figure 4). 
CK12 mRNA was however not observed in oral cells under any conditions (Figure 4). Since several 
studies have used oral epithelium as a negative control for PAX6 [15, 20], these cells were cultured 
in feeder-free, serum-free media (defined KSFM) and protein analysed to see if the low PAX6 
expression was a result of using fibroblasts as a feeder layer. However, PAX6 protein was still 
detected in these KSFM cultured oral epithelial cells; in addition, no protein was detected in any 
fibroblast type (Figure 6). 
 
MUC16 has been shown to be expressed in tissue sections of the corneal epithelium, but not in the 
oral mucosal epithelium [21]. In this study we observed high MUC16 protein expression in limbal 
epithelial cells co-cultured with all fibroblast types (Figure 5). MUC16 protein expression in oral 
epithelial cells was also observed on all fibroblast feeder layers (Figure 5) however it was highly 
variable with cells cultured on 3T3 demonstrating expression in cultures derived from only one of 
the donors and low levels expressed in cells from all donors cultured on limbal or oral fibroblasts. 
These levels of MUC16 protein expression were all significantly lower than those observed in limbal 
epithelial cells cultured on limbal fibroblasts (P<0.05, One way ANOVA, Bonferroni’s multiple 
comparison test). MUC16 mRNA was expressed in all epithelial-fibroblast co-cultures studied (Figure 
4).  
 
 
Epithelial cultures initiated using HOMF as a feeder layer 
HOMF were observed to support the primary expansion of HLE as shown in Figure 7. HLE cultures 
were set up from 5 eyes from 4 different donors. 4 of the 5 cultures reached confluency by day 6. 
The culture that did not reach confluency by this time was initiated from one of a pair of donor eyes 
of which HLE from the other one reached confluency by day 6 perhaps suggesting poor tissue quality 
since all other culture conditions were the same including HOMF. Thus, we observed successful 
primary epithelial expansion on HOMF for 4/4 different HLE donors. 
 
 
 
 Figure 1. HLE and HOME can be successfully expanded using 3T3, HLF, or HOMF as feeder 
fibroblasts. Cells with epithelial morphology were observed for all cultures with areas of epithelial 
cells shown here for each epithelial-fibroblast co-culture. Images for HLE are of cells from the same 
HLE donor. Images for HOME are of cells from the same HOME donor. Images were taken at passage 
1. Scale bar = 200micron.  
 
 
 
 
  
 
Figure 2: Population doublings obtained for HLE and HOME expanded on 3T3, HLF or HOMF feeder 
layers. Epithelial cells were initially expanded on 3T3, and then split equally onto 3T3, HLF, and 
HOMF feeder layers and cultured on these feeder layers until they ceased to proliferate any further. 
Population doublings were calculated from p1 until senescence i.e. expansion in the primary culture 
not included. n=3 (3 HLE donors, and 3 HOME donors). P<0.05, one way ANOVA compared to 3T3 
controls. The number of epithelial population doublings observed using HOMF as feeder fibroblasts 
was comparable to that obtained using the gold standard 3T3 feeder fibroblasts. The number of 
epithelial population doublings obtained on HLF feeder layers was however significantly lower than 
that obtained with the gold standard 3T3 expansion method.  
 Figure 3. Colony forming efficiency of HLE and HOME cultured on 3T3, HLF and HOMF from 
passage 1 and passage 2 cells. A. The number of colonies greater than 2mm in diameter was used in 
the colony forming efficiency calculation thus excluding aborted colonies (paraclones) from the 
analysis and giving a more accurate measure of proliferative ability than total CFE. Results shown are 
based on n=3 HLE donors, and n=3 HOME donors with 3 wells analysed per condition. For HLE, 
HOMF was comparable to 3T3 for both passage 1 and 2. HLF co-cultured HLE had a significantly 
lower CFE (P<0.05, one way ANOVA) than 3T3 controls at passage 2. For HOME, no significant 
difference was observed between HOMF or HLF and 3T3. Mean values with SD error bars are shown. 
B. Examples of colonies obtained from each epithelial-fibroblast group. Results shown are from wells 
in which 500 epithelial cells were seeded, apart from the passage 1 HOME-fibroblast groups where 
examples shown are with 250 epithelial cells seeded/well.  
 
 
 
 
 
Figure 4. PCR expression of corneal markers and putative stem cell markers for HLE and HOME 
cultured on 3T3, HOMF, and HLF. The corneal markers PAX6 and MUC16 were detected in epithelial 
cells (both HLE and HOME) cultured on all three feeder fibroblast types, however CK12 was negative 
for oral epithelial cells. The putative stem cell markers CK15, ABCG2, and deltaNp63α were detected 
in both limbal and oral epithelial cells cultured on all fibroblast types. Representative results are 
shown. Three experiments were performed with different donors with similar results. 
  
Figure 5. Western blot analysis of HLE and HOME cultured on different feeder layers: 3T3, HLF, and 
HOMF. A. Expression of PAX6, p63α, MUC16 and CK15 are shown. These values are normalised to 
GAPDH and relative to HLE cultured on 3T3. Low levels of PAX6 were observed for HOME cultured on 
all three feeder fibroblast types, and epithelial PAX6 expression for HLE on HLF or HOMF was 
comparable to that of HLE on 3T3. P63α was expressed in higher levels in HOME than HLE. High 
levels of MUC16 were expressed in HLE cultured on all three feeder fibroblast types. Lower levels of 
MUC16 were observed for all HOME cultured on HLF or HOMF, and only 1/3 cultures on 3T3 
expressed this protein. Two bands were observed for CK15, a band at approximately 50kDa (CK15 
upper) and a band at approximately 45kDa (CK15 lower). The upper band was observed in both 
limbal and oral epithelial cells whereas the lower band was present only in HLE. For HLE cultured on 
the 3 different feeder fibroblast types, no significant difference in protein expression was observed 
between these groups for any of the proteins tested. For HOME cultured on the 3 different feeder 
fibroblast types, the only significant difference in protein expression observed was between HOME 
cultured on 3T3 and HOME cultured on HOMF for CK15 (upper band). *P<0.05 (one way ANOVA) 
compared to HLE (cultured on a 3T3 feeder layer) unless otherwise indicated. N=3, apart from the 
PAX6 graph where n=4 HLE donors. B. Example blots are shown for each of the markers tested.  
 
 
 
 
 Figure 6. PAX6 expression in HOME cultured with and without feeder fibroblasts. A. PCR expression 
of PAX6 for the following: HLE and HOME cultured on a 3T3 feeder layer, HOME cultured in a serum-
free feeder-free culture system with KSFM, 3T3, HLF and HOMF. No sample and no AMV reverse 
transcriptase (no AMV RT) controls were included. Low levels of PAX6 were detected in HOME 
cultured with and without 3T3, and also in HLF and HOMF. No PAX6 expression was observed in 3T3. 
B. Western blot showing the expression of PAX6 protein in the various cell types tested. C. Western 
blot densitometric analysis. PAX6 was normalised to GAPDH and values are relative to HLE-3T3. N=1. 
Western blotting confirmed that PAX6 was greatly expressed in HLE cells, with low expression in 
HOME cells cultured with and without 3T3s. No PAX6 protein was detected in any of the feeder 
fibroblasts tested. 
Figure 7. Primary expansion of HLE on HOMF. HOMF were shown to support primary epithelial 
expansion for 4 different HLE donors. Representative images are shown at day 1 and day 6. Colonies 
of HLE consisting of small tightly packed cells were observed on day 1 (a, b), arrows indicate the 
epithelial colony edge. Confluent cultures were obtained by day 6 with cells displaying typical 
epithelial morphology (c, d). Scale bars are 200µm.  
 
Discussion: 
Results from this study suggest that human oral mucosal fibroblasts could be used as an alternative 
feeder fibroblast to 3T3s for producing cultured epithelial cells (derived both from the limbus and 
the oral cavity) for use in the clinic to treat patients with LSCD. Oral fibroblasts were found to be 
comparable to 3T3s for use as a feeder fibroblast for expanding both types of epithelial cells tested 
in terms of number of population doublings, and maintenance of the putative stem cell marker 
p63α. For limbal epithelial cells, CK15 expression was also comparable when oral fibroblasts and 
3T3s were used as a feeder layer as was expression of the corneal markers PAX6, MUC16 and CK12. 
For oral epithelial cells, expression of the corneal markers PAX6 and MUC16 was also similar 
following co-culture with either oral or 3T3 feeder fibroblasts. 
For the clinic, to eliminate 3T3 completely from the culture system would be ideal. Now we have 
demonstrated that following primary epithelial expansion on 3T3, HOMF is comparable to 3T3 as a 
feeder fibroblast for a number of parameters, and may therefore have application for production of 
clinical grafts the next step would be to perform GMP validation experiments on cultures initiated on 
HOMF e.g. to assess the percentage of stem cells and the expression of CK12 in the epithelial 
cultures. The number of stem cells in limbal epithelial cultures for the treatment of LSCD is 
important for clinical success. A minimum of 3% stem cells (detected as p63-bright holoclone 
forming stem cells) in such cultures has been shown to be associated with successful transplants 
[22]. In this study the epithelial cells were cultured as a monolayer. Airlifting to induce cell 
differentiation and stratification is commonly performed prior to transplantation. The differentiation 
marker CK12 would be increased in such conditions. Although we have shown here that HOMF can 
support primary HLE cultures, further validation would be needed to enable their use as a clinical 
feeder layer. 
We used CK15 and p63α as putative stem cell markers, and MUC16 and PAX6 as corneal markers. 
CK3 was not used as a corneal marker since CK3 is expressed by HOME as well as HLE [18]. CK12 was 
not detected by PCR in HOME on any of the feeder layers. We tried various different CK12 antibodies 
for western blotting for HLE-fibroblast and HOME-fibroblast cultures with no success. However, 
CK3/12 is expressed in differentiated cells and may therefore be more likely to be detected if 
stratification had been induced e.g. by airlifting. p63α antibody was used in this study, p63α is a 
stem cell marker expressed only in the basal corneal epithelium. HLE are not maintained in culture 
as long as HOME as demonstrated in this study (fibroblast co-culture method). By passage 2 HLF 
cultured HLE have low CFE which correlates with lower p63α observed for HLE than HOME. 
Interestingly we observed low levels of PAX6 in oral epithelial cells cultured on all fibroblast types. 
Although several studies have shown cultured HOME to be PAX6 negative [15, 20, 23], a recent 
study found PAX6 expression in human oral mucosal tissue [24]. More specifically, faint pan-nuclear 
PAX6 staining was observed in the oral mucosal epithelium [24]. Since PAX6 is expressed in the oral 
mucosal epithelium in vivo, cultured HOME should have the potential to express PAX6 which was 
shown in this study. PAX6 is important for maintaining a normal corneal epithelial phenotype and is 
downregulated or absent in epithelial cells from patients with various ocular surface diseases [20]. It 
therefore seems advantageous for HOME used for COMET to express PAX6. 
Mucins are important for maintaining the tear film on the surface of the eye which provides 
lubrication and a barrier to pathogen entry. MUC16 is a cell-surface associated mucin expressed in 
the corneal epithelium and dysregulation of this mucin may be associated with dry eye pathology 
[25]. Hori et al (2008) have shown that MUC16 is expressed in tissue sections of the corneal 
epithelium, but not the oral mucosal epithelium. The authors did however state that MUC16 may 
have been lost during pre-treatment prior to harvest of the oral mucosal tissue. In this study we 
observed lower MUC16 expression in oral epithelial cells compared to those derived from the 
limbus; the expression in limbal cells was not significantly different between any of the fibroblast 
types tested. The maintenance of this mucin in HLE regardless of the feeder fibroblast used for 
expansion may be important for function of these cells on the eye post-transplantation. MUC16 was 
also observed by PCR for oral epithelial cells irrespective of which fibroblasts were used as a feeder 
layer. MUC16 protein was detected in 3/3 HOME samples co-cultured with HLF or HOMF and 1/3 
3T3 co-cultured HOME. Limbal and oral fibroblasts are therefore as good as, and possibly better than 
3T3 for use as feeder fibroblasts for supporting oral epithelial cells in terms of MUC16 expression. 
Other studies have also shown MUC16 expression in cultured HOME [21, 26]. These studies used 3T3 
as a feeder fibroblast, and looked at MUC16 expression in stratified cell sheets. The next iteration of 
the system described here in which cells were cultured as a monolayer could therefore be the 
induction of a stratified cell sheet to enhance the expression of MUC16 expression in oral epithelial 
cells. 
 
Other studies have shown that human embryonic stem cells and murine hair follicle stem cells can 
be directed towards a more corneal like lineage using a combination of extracellular matrix and 
limbal fibroblast conditioned media [27, 28]. In these studies CK12 [27, 28] and Pax6 [28] were 
upregulated. Since CK12 was not expressed in any of the oral epithelial cultures in this study, and 
PAX6 and MUC16 were not significantly different for HOME co-cultured with limbal or epithelial 
fibroblasts our data suggests that more than just fibroblasts are required to direct HOME towards a 
more corneal-like phenotype.An advantage of feeder layer pre-expansion of epithelial cells over 
explant techniques for cell therapy, is the provision of sufficient cells for quality control testing e.g. 
p63 [22]. Pre-expansion also facilitates greater characterisation of the cells. Epithelial cells for use in 
the clinic to treat LSCD typically only have one expansion step on 3T3. Although all epithelial cells 
studied were initially expanded on 3T3 for the primary culture, they were subjected to one or two 
further expansion steps on the different fibroblast feeder types prior to phenotypic analysis. It is 
possible that greater differences in epithelial phenotype may be observed if HLE and HOME were 
expanded directly onto HLF and HOMF feeder layers following isolation. Oral fibroblasts are an 
attractive source of feeder cells as they can be easily isolated from a biopsy from the readily 
accessible oral mucosal epithelium, a procedure in which the biopsy area heals quickly with minimal 
scarring. These oral cells could also be an autologous source of fibroblasts from the patient, which 
used together with autologous epithelial (limbal or oral) cells would mean the patient would not 
require immunosuppression to prevent graft rejection. Alternatively, oral fibroblasts cells from one 
donor (cadaveric or living) could be screened and banked to produce grafts for multiple patients.For 
the treatment of unilateral LSCD autologous HLE could be expanded on autologous HOMF. For 
bilateral LSCD treatment autologous HOME could be expanded on autologous HOMF. For both 
treatment types 2 biopsies would need to be taken from the patient. An oral mucosal biopsy would 
firstly be required from which to isolate HOMF, and once these are suitably expanded, a second 
biopsy (either limbal or oral) from which to isolate epithelial cells. In this study HOMF were obtained 
using explant culture. Using this method of isolation it would take approximately 5 weeks to obtain 
enough passage 1 HOMF for use as a feeder layer (in this study confluent passage 1 cultures were 
obtained after 5 weeks in culture, although we used these cells as feeder fibroblasts at a later 
passage number). Typically 2 weeks are required for epithelial expansion on fibroblasts for CLET or 
COMET. Thus it may take approximately 7 weeks for graft production. Other methods of fibroblast 
isolation may be quicker e.g. collagenase digestion, but the population of fibroblasts obtained may 
be different.  
In this study limbal fibroblasts were not as good as the gold standard 3T3 for maintaining HOME and 
HLE cells in culture. Although protein expression of CK15 and p63α was not significantly different for 
HOME or HLE cultured on HLF and 3T3 at passage 2, HLF were not found to be equivalent to 3T3 in 
terms of maintaining the proliferative ability of the epithelial cells. The number of population 
doublings was significantly less for HLE and HOME cultured on HLF compared to 3T3 and HOMF. It is 
possible that a different population of fibroblasts from the limbus or cornea may be better as a 
feeder layer. For example, corneal stromal stem cells have been found to generate a better corneal 
stromal tissue equivalent than human corneal fibroblasts [29] and may be more successful as a 
feeder layer than the limbal fibroblasts used here. Since limbal epithelial stem cells are not uniformly 
distributed along the limbus but preferentially located in certain areas [30-32] fibroblasts from these 
areas of the limbus may also be better for maintaining epithelial stem cells in culture. 
 
Conclusion: 
Fibroblasts derived from the human oral mucosa could be used as an alternative feeder fibroblast to 
murine 3T3 for the culture of epithelial cells for use in the clinic; oral fibroblasts can easily be 
isolated from a small buccal oral mucosal biopsy taken from the patient and this biopsy area heals 
quickly with minimal scarring. Removal of these animal derived 3T3 from the culture system would 
improve the safety of the procedure. Another advantage of oral fibroblasts is that they can be 
autologous. Thus for COMET or CLET, autologous fibroblasts could be used to expand autologous 
epithelial cells derived either from the eye (limbus) or the mouth (oral mucosa) and thus remove the 
requirement for immunosuppression and its associated side effects.  
 
Future perspective:  
There are now several human feeder fibroblast types that show promise as being suitable 
alternatives to 3T3 for the expansion of epithelial cells for clinical use. These include: oral mucosal 
fibroblasts described here,  tenon’s fibroblasts [7], dermal fibroblasts [8], mesenchymal stem-cell 
derived feeder cells [9], the embryonic fibroblast cell line MRC-5 [10], and the commercially 
available newborn foreskin fibroblast cell lines Hs68 and CCD1112Sk [11]. These have yet to be used 
in production of epithelial cells for the treatment of LSCD but it seems the use of a 3T3 alternative 
may not be to be too far away. In addition to replacing 3T3 with human feeder fibroblasts for the 
culture of epithelial cells, animal derived products e.g. bovine serum should also be removed from 
the culture medium (or human-derived alternatives found) to further improve the safety of cultured 
cells for patients. The ideal would be to have an autologous cell product produced using a fully 
defined and animal product free culture system. Investigations are currently underway with the aim 
of producing cell therapies without the use of animal derived products which are of comparable 
quality and efficacy to those achieved using the current gold standard approach which utilises 3T3 
and FBS.  
 
Executive summary: 
Cultured epithelial cell therapy for the treatment of LSCD 
• LSCD can be successfully treated with cultured epithelial cells derived from the human eye 
(limbus) or mouth (oral mucosa) 
• The current gold standard method for expanding these epithelial cells for clinical use uses a 
3T3 feeder fibroblast layer.  
• Ideally the procedure for producing these cells should be animal product free. However 3T3 
may be permitted on a case-by case basis until an alternative can be found. 
Human oral mucosal fibroblasts as an equivalent, safer, feeder fibroblast to 3T3 for epithelial 
expansion 
• HOMF are human-derived, autologous feeder fibroblasts that can be cultured from an easily 
accessible oral mucosal biopsy which heals quickly with minimal scarring. 
• Oral fibroblasts are equivalent to 3T3 as a feeder fibroblast for the culture of epithelial cells 
(derived from both the limbus and the oral mucosa) in terms of total passage number, 
population doublings, and expression of the putative stem cell marker p63α. 
• Expression of the corneal markers PAX6 and MUC16 is maintained when limbal epithelial 
cells are co-cultured on an oral mucosal fibroblast feeder layer. 
• Oral fibroblasts could be used as a feeder layer instead of murine 3T3 for the culture of a 
variety of epithelial cells for use in cultured stem cell therapy for the treatment of LSCD. This 
system could improve the safety of these procedures, by utilising an autologous source of 
feeder cells. 
• Oral fibroblasts could potentially be used to culture other epithelial cell types for clinical use. 
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